The novel coronavirus first identified at the end of 2019 continues to plague the world. ABclonal hopes to support medical researchers and healthcare providers worldwide by providing high quality, reliable research and diagnostic materials.

Advantages

Stringent quality control

Bulk in stock

Cost-effective

Raw Materials for COVID-19 Nucleic Acid Diagnostic Kit
Request for bulk pricing